Hay DL - Search Results

1

Migraine: disease characterisation, biomarkers, and precision medicine.

Ashina M, Terwindt GM, Al-Karagholi MA, de Boer I, Lee MJ, Hay DL, Schulte LH, Hadjikhani N, Sinclair AJ, Ashina H, Schwedt TJ, Goadsby PJ. Ashina M, et al. Among authors: hay dl. Lancet. 2021 Apr 17;397(10283):1496-1504. doi: 10.1016/S0140-6736(20)32162-0. Epub 2021 Mar 25. Lancet. 2021. PMID: 33773610 Review.

2

Amylin Analog Pramlintide Induces Migraine-like Attacks in Patients.

Ghanizada H, Al-Karagholi MA, Walker CS, Arngrim N, Rees T, Petersen J, Siow A, Mørch-Rasmussen M, Tan S, O'Carroll SJ, Harris P, Skovgaard LT, Jørgensen NR, Brimble M, Waite JS, Rea BJ, Sowers LP, Russo AF, Hay DL, Ashina M. Ghanizada H, et al. Among authors: hay dl. Ann Neurol. 2021 Jun;89(6):1157-1171. doi: 10.1002/ana.26072. Epub 2021 Apr 8. Ann Neurol. 2021. PMID: 33772845 Free PMC article. Clinical Trial.

3

Effect of Adrenomedullin on Migraine-Like Attacks in Patients With Migraine: A Randomized Crossover Study.

Ghanizada H, Al-Karagholi MA, Arngrim N, Mørch-Rasmussen M, Walker CS, Hay DL, Ashina M. Ghanizada H, et al. Among authors: hay dl. Neurology. 2021 May 18;96(20):e2488-e2499. doi: 10.1212/WNL.0000000000011930. Epub 2021 Apr 7. Neurology. 2021. PMID: 33827963

4

Is calcitonin gene-related peptide a reliable biochemical marker of migraine?

Tesfay B, Karlsson WK, Moreno RD, Hay DL, Hougaard A. Tesfay B, et al. Among authors: hay dl. Curr Opin Neurol. 2022 Jun 1;35(3):343-352. doi: 10.1097/WCO.0000000000001053. Curr Opin Neurol. 2022. PMID: 35674078 Review.

5

CGRP receptor antagonists for migraine. Are they also AMY₁ receptor antagonists?

Garelja ML, Walker CS, Hay DL. Garelja ML, et al. Among authors: hay dl. Br J Pharmacol. 2022 Feb;179(3):454-459. doi: 10.1111/bph.15585. Epub 2021 Jun 24. Br J Pharmacol. 2022. PMID: 34076887 Free article. Review.

6

Beyond CGRP: The calcitonin peptide family as targets for migraine and pain.

Rees TA, Hendrikse ER, Hay DL, Walker CS. Rees TA, et al. Among authors: hay dl. Br J Pharmacol. 2022 Feb;179(3):381-399. doi: 10.1111/bph.15605. Epub 2021 Jul 27. Br J Pharmacol. 2022. PMID: 34187083 Free PMC article. Review.

7

Pharmacological characterisation of mouse calcitonin and calcitonin receptor-like receptors reveals differences compared with human receptors.

Garelja ML, Bower RL, Brimble MA, Chand S, Harris PWR, Jamaluddin MA, Petersen J, Siow A, Walker CS, Hay DL. Garelja ML, et al. Among authors: hay dl. Br J Pharmacol. 2022 Feb;179(3):416-434. doi: 10.1111/bph.15628. Epub 2021 Oct 15. Br J Pharmacol. 2022. PMID: 34289083 Free PMC article.

8

Atogepant (Qulipta®) for migraine prevention.

Hay DL, Walker CS, Harris PWR. Hay DL, et al. Trends Pharmacol Sci. 2022 Aug;43(8):701-702. doi: 10.1016/j.tips.2022.03.013. Epub 2022 Apr 22. Trends Pharmacol Sci. 2022. PMID: 35469689 No abstract available.

9

Regulation of signal transduction by calcitonin gene-related peptide receptors.

Walker CS, Conner AC, Poyner DR, Hay DL. Walker CS, et al. Among authors: hay dl. Trends Pharmacol Sci. 2010 Oct;31(10):476-83. doi: 10.1016/j.tips.2010.06.006. Epub 2010 Jul 13. Trends Pharmacol Sci. 2010. PMID: 20633935 Review.

10

CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?

Walker CS, Hay DL. Walker CS, et al. Among authors: hay dl. Br J Pharmacol. 2013 Dec;170(7):1293-307. doi: 10.1111/bph.12129. Br J Pharmacol. 2013. PMID: 23425327 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page